Crystal Forms and Production Methods Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 62/594,851, filed Dec 5, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,377,708 | Crystal Forms and Production Methods Thereof In force · High confidence | Sunovion Pharmaceuticals Inc. | In force | High confidence | ||
| US 10,577,317 | Crystal Forms and Production Methods Thereof In force · High confidence | Sunovion Pharmaceuticals Inc. | In force | High confidence | ||
| US 10,800,738 | Crystal Forms and Production Methods Thereof In force · High confidence | Sunovion Pharmaceuticals Inc. | In force | High confidence | ||
| US 11,767,293 | Crystal Forms and Production Methods Thereof In force · High confidence | Sunovion Pharmaceuticals Inc. | In force | High confidence | ||
| US 11,370,753 | Crystal Forms and Production Methods Thereof Lapsed Jun 28, 2026 on the fee record High confidence | Sunovion Pharmaceuticals Inc. | Lapsed Jun 28, 2026 on the fee record | High confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Sunovion Pharmaceuticals Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.